Suppr超能文献

脱氢表雄酮 - S 水平与绝经后女性心血管疾病死亡率:来自美国国立卫生研究院 - 国家心肺血液研究所(NHLBI)赞助的女性缺血综合征评估(WISE)的结果。

DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE).

机构信息

Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.

出版信息

J Clin Endocrinol Metab. 2010 Nov;95(11):4985-92. doi: 10.1210/jc.2010-0143. Epub 2010 Aug 25.

Abstract

CONTEXT

Dehydroepiandrosterone sulfate (DHEA-S), a major circulating sex steroid prohormone, declines with age. Low levels have been associated with increased cardiovascular disease (CVD) risk and all-cause mortality, although these results have not been consistently replicated, particularly in women.

OBJECTIVE

Our objective was to examine the association of circulating DHEA-S levels, CVD, and mortality risk among postmenopausal women with suspected myocardial ischemia.

DESIGN

In the Women's Ischemia Syndrome Evaluation, 270 postmenopausal women underwent coronary angiography and blood hormone levels for suspected ischemia and were followed annually. The primary outcome of interest was CVD mortality; secondary analyses included all-cause mortality and nonfatal CVD events (myocardial infarction, stroke, and congestive heart failure) and angiographic obstructive coronary artery disease (CAD).

RESULTS

Women in the lowest DHEA-S tertile had higher CVD mortality (17% 6-yr mortality rate vs. 8%; log-rank P = 0.011), and all-cause mortality (21 vs. 10%; P = 0.011) compared with women with higher DHEA-S levels. The increased CVD mortality risk [hazard ratio (HR) = 2.55; 95% confidence interval (CI) = 1.19-5.45] remained unchanged after adjustment for multiple CVD risk factors (HR = 2.43; 95% CI = 1.06-5.56) but became nonsignificant when further adjusting for the presence or severity of angiographic obstructive CAD (HR = 1.99; 95% CI = 0.87-4.59). Results were similar for all-cause mortality. Lower DHEA-S levels were only marginally but not independently associated with obstructive CAD.

CONCLUSIONS

Among postmenopausal women with coronary risk factors undergoing coronary angiography for suspected myocardial ischemia, lower DHEA-S levels were linked with higher CVD mortality and all-cause mortality. Our study provides valuable feasibility data useful for future investigations and possible mechanistic pathways.

摘要

背景

硫酸脱氢表雄酮(DHEA-S)是一种主要的循环性激素前体,随着年龄的增长而下降。低水平与心血管疾病(CVD)风险和全因死亡率增加有关,但这些结果并未得到一致证实,尤其是在女性中。

目的

我们的目的是研究绝经后疑似心肌缺血女性的循环 DHEA-S 水平、CVD 和死亡风险之间的关系。

设计

在女性缺血综合征评估中,270 名绝经后女性接受了冠状动脉造影和血液激素水平检查,以评估疑似缺血情况,并每年进行随访。主要研究终点为 CVD 死亡率;次要分析包括全因死亡率和非致死性 CVD 事件(心肌梗死、卒中和充血性心力衰竭)以及血管造影阻塞性冠状动脉疾病(CAD)。

结果

DHEA-S 水平最低的三分位女性的 CVD 死亡率(6 年死亡率为 17% vs. 8%;log-rank P = 0.011)和全因死亡率(21% vs. 10%;P = 0.011)均高于 DHEA-S 水平较高的女性。调整多种 CVD 危险因素后,CVD 死亡风险增加(风险比 [HR] = 2.55;95%置信区间 [CI] = 1.19-5.45)仍然不变(HR = 2.43;95% CI = 1.06-5.56),但当进一步调整血管造影阻塞性 CAD 的存在或严重程度时,该风险比变得无统计学意义(HR = 1.99;95% CI = 0.87-4.59)。全因死亡率的结果相似。较低的 DHEA-S 水平仅略有但并非独立与阻塞性 CAD 相关。

结论

在接受冠状动脉造影检查以评估疑似心肌缺血的有冠状动脉风险因素的绝经后女性中,较低的 DHEA-S 水平与 CVD 死亡率和全因死亡率增加相关。我们的研究提供了有价值的可行性数据,可用于未来的研究和可能的机制途径。

相似文献

引用本文的文献

5
Novel Antidiabetic Medications in Polycystic Ovary Syndrome.多囊卵巢综合征中的新型抗糖尿病药物
Discoveries (Craiova). 2022 Mar 31;10(1):e145. doi: 10.15190/d.2022.4. eCollection 2022 Jan-Mar.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验